TCL Archive FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract January 23, 1987
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: Thomas King Names Special Assistant To Lombardi Center Director; John MacDonald Takes U. Ky. Job March 30, 1984
TCL Archive In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available March 18, 1994
